C-RAD develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer. The Company operates through two segments: Positioning and Imaging. Its products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst HD, a surface image guided radiation therapy solution; Catalyst, a revolution in 4D treatment; Catalyst PT, an advanced solution for particle therapy; Catalyst Tomo, an enhanced positioning solution for tomotherapy; Cyrpa laser positioning products; and Gemini, an X-ray detector optimized for electronic portal imaging device in radiation therapy. The Company offers installation, application training, and aftersales services.
Revenue (FY, 2018)
Gross profit (FY, 2018)
Net income (FY, 2018)
EBITDA (FY, 2018)
EBIT (FY, 2018)
Market capitalization (23-May-2022)
Closing stock price (23-May-2022)
Cost of goods sold
Depreciation and Amortization
C-RAD revenue breakdown by business segment: 99.7% from POSITIONING EXTERN CUSTOMERS and 0.3% from Other
When was C-RAD founded?
C-RAD was founded in 2004.
Who are C-RAD key executives?
C-RAD's key executives are Lars Nyberg, Kicki Wallje-Lund and Peter Hamberg.
How many employees does C-RAD have?
C-RAD has 66 employees.
What is C-RAD revenue?
Latest C-RAD annual revenue is kr190.1 m.
What is C-RAD revenue per employee?
Latest C-RAD revenue per employee is kr2.9 m.
Who are C-RAD competitors?
Competitors of C-RAD include Kromek, SamanTree Medical and RTsafe.
Where is C-RAD headquarters?
C-RAD headquarters is located at Bredgränd 14, Uppsala.
Where are C-RAD offices?
C-RAD has offices in Uppsala, Delray Beach and Berlin.
How many offices does C-RAD have?
C-RAD has 5 offices.
Receive alerts for 300+ data fields across thousands of companies